acipimox: Clinical Trials

3 trials of acipimox, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 22Completed 2

Follow acipimox: new trials by email Literature Review of acipimox trials Research Report on acipimox

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Impact of Free Fatty Acid (FFA-) Suppression on Myocardial Lipids and Function in Patients With Type 2 Diabetes
acipimox, Placebo Oral Capsule - Type 2 Diabetes
Phase 2 / Phase 3CompletedMedical University of Vienna82013-10-012017-04-04
Effects of Acipimox on Insulin Action, Vascular Function, and Muscle Function in Type 1 Diabetes
Acipimox, Placebo - Type 1 Diabetes
Phase 3CompletedUniversity of Colorado, Denver282011-06-012022-01-21
The Impact of Free Fatty Acid Reduction on Vascular Function in the Metabolic Syndrome
acipimox, Placebo - Metabolic Syndrome
Phase 2 / Phase 3CompletedBrigham and Women's Hospital402006-04-012023-02-21

Conditions studied

Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Insulin Resistance (1)  ·  Metabolic Syndrome (1)

Sponsors

Brigham and Women's Hospital (1)  ·  Medical University of Vienna (1)  ·  University of Colorado, Denver (1)

Countries

United States (2)  ·  Austria (1)

Top investigators

Irene Schauer, MD, PhD (1)  ·  Joshua A. Beckman, M.D. (1)  ·  Michael Krebs, Prof.MD (1)

Results publications

PMID 31571412, PMID 39888728